Mutation analysis of the IL36RN gene in Chinese patients with generalized pustular psoriasis with/without psoriasis vulgaris

Journal of Dermatological Science

Volumn 76, Issue 2, 2014, Pages 132-138

  Li, Xiuyan ^a,b   Chen, Mingfei ^a,b   Fu, Xi'an ^a,b   Zhang, Qilin ^e   Wang, Zhenzhen ^a,b   Yu, Gongqi ^a,b   Yu, Yongxiang ^a,b   Qin, Peipei ^a,b   Wu, Weizhi ^c,d   Pan, Futang ^c,d   Liu, Hong ^a,b,c,d   Zhang, Furen ^a,b,c,d  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^b Shandong Provincial Key Lab for Dermatovenereology   (China)

^c SHANDONG UNIVERSITY   (China)

^d Shandong Provincial Medical Center for Dermatovenereology   (China)

^e SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Generalized pustular psoriasis (GPP); GPP with preceding, later or accompanied by PV (GPP with PV); GPP without psoriasis PV (GPP alone); Interleukin 36 receptor antagonist (IL36RN); Mutation analysis; Psoriasis vulgaris (PV)

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GENE; GENE MUTATION; GENERALIZED PUSTULAR PSORIASIS; GENETIC HETEROGENEITY; HAN CHINESE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN TISSUE; INTERLEUKIN 36 RECEPTOR ANTAGONIST GENE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PSORIASIS VULGARIS; PUSTULAR PSORIASIS; SCHOOL CHILD; YOUNG ADULT;

EID: 84908037660     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2014.08.007     Document Type: Article

References (20)

1. Sugiura K., Takemoto A., Yamaguchi M., Takahashi H., Shoda Y., Mitsuma T., et al. The majority of generalized pustular psoriasis without psoriasis vulgaris is caused by deficiency of interleukin-36 receptor antagonist. J Invest Dermatol 2013, 133:2514-2521.
2. Li M., Han J., Lu Z., Li H., Zhu K., Cheng R., et al. Prevalent and rare mutations in IL-36RN gene in Chinese patients with generalized pustular psoriasis and psoriasis vulgaris. J Invest Dermatol 2013, 133:2637-2639.
3. Marrakchi S., Guigue P., Renshaw B.R., Puel A., Pei X.Y., Fraitag S., et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med 2011, 365:620-628.
4. Farooq M., Nakai H., Fujimoto A., Fujikawa H., Matsuyama A., Kariya N., et al. Mutation analysis of the IL-36RN gene in 14 Japanese patients with generalized pustular psoriasis. Hum Mutat 2012, 34:176-183.
5. Kanazawa N., Nakamura T., Mikita N., Furukawa F. Novel IL36RN mutation in a Japanese case of early onset generalized pustular psoriasis. J Dermatol 2013, 40:749-751.
6. Körber A., Mössner R., Renner R., Sticht H., Wilsmann-Theis D., Schulz P., et al. Mutations in IL36RN in patients with generalized pustular psoriasis. J Invest Dermatol 2013, 133:2634-2637.
7. Onoufriadis A., Simpson M.A., Pink A.E., Di Meglio P., Smith C.H., Pullabhatla V., et al. Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis. Am J Hum Genet 2011, 89:432-437.
8. Setta-Kaffetzi N., Navarini A.A., Patel V.M., Pullabhatla V., Pink A.E., Choon S.E., et al. Rare pathogenic variants in IL36RN underlie a spectrum of psoriasis-associated pustular phenotypes. J Invest Dermatol 2013, 133:1366-1369.
9. Sugiura K., Takeichi T., Kono M., Ogawa Y., Shimoyama Y., Muro Y., et al. A novel IL-36RN/IL1F5 homozygous nonsense mutation, p.Arg10X, in a Japanese patient with adult-onset generalized pustular psoriasis. Br J Dermatol 2012, 167:699-701.
10. Berki D.M., Mahil S.K., Burden A.D., Trembath R.C., Smith C.H., Capon F., et al. Loss of IL36RN function does not confer susceptibility to psoriasis vulgaris. J Invest Dermatol 2014, 134:271-273.
11. Towne J.E., Garka K.E., Renshaw B.R., Virca G.D., Sims J.E. Interleukin (IL)-1F6 IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs. J Biol Chem 2004, 279:13677-13688.
12. Dinarello C., Arend W., Sims J., Smith D., Blumberg H., O'Neill L., et al. IL-1 family nomenclature. Nat Immunol 2010, 11:973.
13. Sims J.E., Smith D.E. The IL-1 family: regulators of immunity. Nat Rev Immunol 2010, 10:89-102.
14. Blumberg H., Dinh H., Trueblood E.S., Pretorius J., Kugler D., Weng N., et al. Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation. J Exp Med 2007, 204:2603-2614.
15. Blumberg H., Dinh H., Dean C., Trueblood E.S., Bailey K., Shows D., et al. IL-1RL2 and its ligands contribute to the cytokine network in psoriasis. J Immunol 2010, 185:4354-4362.
16. Viguier M., Guigue P., Pages C., Smahi A., Bachelez H. Successful treatment of generalized pustular psoriasis with the interleukin-1-receptor antagonist anakinra: lack of correlation with IL1RN mutations. Ann Intern Med 2010, 153:66-67.
17. Hüffmeier U., Wätzold M., Mohr J., Schön M.P., Mössner R. Successful therapy with anakinra in a patient with generalized pustular psoriasis carrying IL36RN mutations. Br J Dermatol 2014, 170:202-204.
18. Strange A., Capon F., Spencer C.C., Knight J., Weale M.E., Allen M.H., et al. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet 2010, 42:985-990.
19. Johnston A., Xing X., Guzman A.M., Riblett M., Loyd C.M., Ward N.L., et al. IL-1F5, -F6, -F8, and -F9: a novel IL-1 family signaling system that is active in psoriasis and promotes keratinocyte antimicrobial peptide expression. J Immunol 2011, 186:2613-2622.
20. Carrier Y., Ma H.L., Ramon H.E., Napierata L., Small C., O'Toole M., et al. Inter-regulation of Th17 cytokines and the IL-36 cytokines in vitro and in vivo: implications in psoriasis pathogenesis. J Invest Dermatol 2011, 131:2428-2437.